Rights Issue, Controller Loan Repayment and Underwriting Conflict at Mongolian Beverage Group
Mongolian Beverage Group (MBG) has 100 million shares outstanding trading at MNT 1,200. It needs MNT 30 billion for a new bottling plant and proposes a 1-for-3 rights issue at MNT 900 per new share, raising approximately MNT 30 billion before fees. The controlling shareholder holds 45%; a foreign strategic investor holds 20% and tells the board it cannot subscribe because its own credit line is frozen. The underwriter will fully subscribe for any unexercised rights for a 4% fee. The prospectus states that MNT 8 billion of the proceeds will repay an unsecured shareholder loan from the controlling shareholder, which matures next year at 15% interest. Minority shareholders complain that the loan repayment benefits the controller and that the foreign investor's non-participation will increase the controller's stake. The FRC is reviewing the prospectus and has asked for a fairness opinion on the related-party use of proceeds.
1. Calculate the theoretical ex-rights price and the wealth effect for a minority holder with 3,000 shares who does nothing. Explain the value of the rights.
Read the worked answer
TERP = (3 × 1,200 + 1 × 900) / 4 = MNT 1,125. A holder of 3,000 shares receives 1,000 rights. If the holder does nothing and the rights lapse, the share value falls from 3,000 × 1,200 = MNT 3,600,000 to 3,000 × 1,125 = MNT 3,375,000, a loss of MNT 225,000, or 6.25%. The theoretical value of one right is TERP minus the subscription price: 1,125 − 900 = MNT 225. The 1,000 rights are worth MNT 225,000. If the rights are transferable and sold at that value, the holder is made whole before costs. If the rights are non-transferable or the holder cannot sell, the dilution is real. The controller's stake depends on subscription: if it subscribes pro rata, it remains at about 45%; if it does not and the underwriter takes the shares, the controller is diluted. The foreign investor's non-participation alone does not increase the controller's percentage if the controller subscribes fully.
2. Analyse the related-party use of proceeds and the underwriting arrangement. What approval and disclosure issues arise?
Read the worked answer
Related party. The MNT 8 billion loan repayment is a related-party transaction. It should be reviewed by independent directors or the audit committee, supported by a fairness opinion, disclosed in the prospectus and approved by shareholders excluding the controller where the rules require. The loan may be legitimate, but using rights proceeds to repay it transfers value to the controller unless the terms are arm's-length. The 15% interest rate and unsecured status need disclosure and comparison with market terms. Underwriting. The 4% full-underwriting fee and the foreign investor's non-participation should be disclosed. The underwriter's conflict is manageable with sub-underwriting and transparent allocation. Control. The board should publish a post-issue ownership table showing scenarios in which the controller subscribes, does not subscribe, and the underwriter takes up the rights. Minority shareholders need enough information to judge whether the plant and the loan repayment create value.
3. Advise the board on structuring the issue to protect minority shareholders and on the accounting and disclosure treatment.
Read the worked answer
Structure. Make the rights transferable, allow sub-underwriting, publish a clear timetable and disclose fees and use of proceeds line by line. A majority-of-minority vote on the related-party element and an independent fairness opinion are strong protections. If the foreign investor cannot subscribe, the board should consider a sub-underwriter or a clawback so that control does not shift unexpectedly. Accounting. Rights issue costs are deducted from equity. The loan repayment is an extinguishment at carrying amount, with no gain unless the terms are renegotiated. Related-party disclosures are required, including the loan balance, interest and repayment terms. Approval. Obtain FRC prospectus approval, MSE listing approval and shareholder approval for the related-party element. The board should explain the plant's expected return and how the issue price was set, not just state that the proceeds are needed.